Apoptosis and cell cycle aberrations in epithelial odontogenic lesions: An evidence by the expression of p53, Bcl-2 and Bax

Medicina Oral Patologia Oral y Cirugia Bucal

Volumn 23, Issue 2, 2018, Pages e120-e125

  Tenório, Jefferson Da Rocha ^a   Santana, Thalita ^a   Queiroz, Salomão Israel Monteiro Lourenço ^b   De Oliveira, Denise Hélen Imaculada Pereira ^b   Queiroz, Lélia Maria Guedes ^b  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b FEDERAL UNIVERSITY OF RIO GRANDE DO NORTE   (Brazil)

Author keywords

Apoptosis; Apoptosis regulatory proteins; Immunohistochemistry; Odontogenic tumors; P53 tumor suppressor protein

Indexed keywords

APOPTOSIS REGULATORY PROTEIN; CELL CYCLE PROTEIN; PROTEIN BAX; PROTEIN BCL 2; PROTEIN P53; TUMOR MARKER; PROTEIN BCL X;

AMELOBLASTOMA; ANTIGEN RETRIEVAL; APOPTOSIS; ARTICLE; BASAL CELL NEVUS SYNDROME; CANCER GROWTH; CARCINOGENESIS; CELL CYCLE ARREST; CORRELATION ANALYSIS; DISEASE ASSOCIATION; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; MAJOR CLINICAL STUDY; OBSERVATIONAL STUDY; ODONTOGENIC KERATOCYST; ODONTOGENIC TUMOR; PROTEIN EXPRESSION; BIOSYNTHESIS; CELL CYCLE; JAW TUMOR; METABOLISM; ODONTOGENIC CYST; PATHOLOGY; TOOTH DEVELOPMENT;

AMELOBLASTOMA; APOPTOSIS; BCL-2-ASSOCIATED X PROTEIN; BCL-X PROTEIN; CELL CYCLE; HUMANS; IMMUNOHISTOCHEMISTRY; JAW NEOPLASMS; ODONTOGENESIS; ODONTOGENIC CYSTS; TUMOR SUPPRESSOR PROTEIN P53;

EID: 85044337545     PISSN: 16984447     EISSN: 16986946     Source Type: Journal    
DOI: 10.4317/medoral.22019     Document Type: Article

References (20)

1. Mosqueda-Taylor A. New findings and controversies in odontogenic tumors. Med Oral Patol Oral Cir Bucal. 2008;13:18758398.
2. da Silva LP, Serpa MS, Santana T, do Nascimento GJF, de Souza Andrade ES, Sobral APV. Clinicopathological and cell proliferation evaluation of ameloblastomas and keratocystic odontogenic tumors: a 10 year retrospective study. Eur Arch Oto-Rhino-Laryngology. 2016;274:1089–95.
3. Wright JM, Vered M. Update from the 4th Edition of the World Health Organization Classification of Head and Neck Tumours: Odontogenic and Maxillofacial Bone Tumors. Head Neck Pathol. 2017;11:68–77.
4. Tekkesin MS, Mutlu S, Olgac V. Expressions of bax, bcl-2 and ki-67 in odontogenic keratocysts (keratocystic odontogenic tumor) in comparison with ameloblastomas and radicular cysts. Turkish J Pathol. 2012;28:49.
5. Lee SK, Kim YS. Current concepts and occurrence of epithelial odontogenic tumors: I. Ameloblastoma and adenomatoid odontogenic tumor. Korean J Pathol. 2013;47:191–202.
6. Gu XM, Zhao LS, Sun LS, Li TJ. PTCH Mutations in Sporadic and. Biotechnology. 2006;85:859–63.
7. Garg K, Chandra S, Raj V, Fareed W, Zafar M. Molecular and genetic aspects of odontogenic tumors: A review. Iran J Basic Med Sci. 2015;18:529–36.
8. Garcia P, Attardi L. Illuminating p53 function in cancer with genetically engineered mouse models. Semin Cell Dev Biol. 2014;0:74– 85.
9. Bagulkar BB, Gawande M, Chaudhary M, Gadbail AR, Patil S, Bagulkar S. XIAP and Ki-67: A Correlation between antiapop-totic and proliferative marker expression in benign and malignant tumours of salivary gland: An immunohistochemical study. J Clin Diagnostic Res. 2015;9:EC01-EC04.
10. Sauk JJ, Nikitakis NG, Scheper MA. Are we on the brink of non-surgical treatment for ameloblastoma? Oral Surgery, Oral Med Oral Pathol Oral Radiol Endodontology. 2010;110:68–78.
11. Salehinejad J, Zare-Mahmoodabadi R, Saghafi S, Jafarian AH, Ghazi N, Rajaei AR, et al. Immunohistochemical detection of p53 and PCNA in ameloblastoma and adenomatoid odontogenic tumor. J Oral Sci. 2011;53(2):213–7.
12. Shetty DC, Urs AB, Godhi S, Gupta S. Classifying odontogenic keratocysts as benign cystic neoplasms: a molecular insight into its aggressiveness. J Maxillofac Oral Surg. 2010;9:30–4.
13. Sajeevan TP, Saraswathi TR, Ranganathan K, Joshua E, Rao UDK. Immunohistochemical study of p53 and proliferating cell nuclear antigen expression in odontogenic keratocyst and periapical cyst. J Pharm Bioallied Sci. 2014;6:S52-7.
14. Deyhimi P, Hashemzade Z. Comparative study of TGF-alpha and P53 markers’ expression in odontogenic keratocyst and orthokerati-naized odontogenic cyst. Dent Res J (Isfahan). 2012;9:S39-44.
15. Razavi SM, Tabatabaie SH, Hoseini AT, Hoseini ET, Khabazian A. A comparative immunohistochemical study of Ki-67 and Bcl-2 expression in solid ameloblastoma and adenomatoid odontogenic tumor. Dent Res J (Isfahan). 2012;9:192-7.
16. Sindura C, Babu C, Mysorekar V, Kumar V. Study of immunohistochemical demonstration of Bcl-2 protein in ameloblastoma and keratocystic odontogenic tumor. J Oral Maxillofac Pathol. 2013;17:176–80.
17. Sreedhar G, Raju MV, Metta KK, Manjunath S, Shetty S, Agarw-al RK. Immunohistochemical analysis of factors related to apoptosis and cellular proliferation in relation to inflammation in dentigerous and odontogenic keratocyst. J Nat Sci Biol Med. 2014;5:112–5.
18. Amaral FR, Mateus GCP, Bonisson LA, de Andrade BAB, Mesquita RA, Horta MCR, et al. Cell proliferation and Apoptosis in Ameloblastomas and keratocystic odontogenic tumors. Braz Dent J. 2012;23:91–6.
19. González-González R, Molina-Frechero N, Damian-Matsumura P, Salazar-Rodriguez S, Bologna-Molina R. Immunohistochemical expression of Survivin and its relationship with cell apoptosis and proliferation in ameloblastomas. Dis Markers. 2015;2015:301781.
20. Rangiani A, Motahhary P. Evaluation of bax and bcl-2 expression in odontogenic keratocysts and orthokeratinized odontogenic cysts: A comparison of two cysts. Oral Oncol. 2009;45:e41-4.